Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + amodiaquine for uncomplicated Plasmodium falciparum malaria in children in Chad
ACTRN12615000893505Phase 4Completed
- Sponsor
- Ministry of Health of Chad
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and amodiaquine in malaria and Falciparum malaria (PF), sponsored by Ministry of Health of Chad. Primary endpoints: Treatment failure rate, Adequate clinical and parasitological response and 2 more. Started Nov 2015; status: completed.
02
Drugs
artesunateamodiaquine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12615000893505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000893505.